APP and neoplasm: The expression of APP at cancer stages, tumor grades, KIRC subtype, nodal metastasis status, patients’ gender, and age, and in the TCGA database showed that the down-regulation of APP expression nearly existed in all subtypes of KIRC (Fig. 8a–f).